Zimbabwe has rejected a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of Washington's request for sensitive information.
This move came to light following a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official spokesman has since explained that the United States was requesting health data for scientific study and commercial purposes but refused to share the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged further talks to reach a agreement suitable to all parties so the country's vital HIV treatment initiative can continue.
Wider Implications
Zimbabwe's decision follows a comparable case in Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the safety of Kenyans' health data.
Since resuming office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had managed assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
Based on reports, 16 African countries have so far agreed to similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data for a long time, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the raw materials for medical research with no assurance that the end products would be available to our population should a future pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining frameworks previously set up via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This framework is intended to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent co-operation could be structured in a way that honours the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that talks need to persist given that much of the country's Aids initiatives relied on external financing.
"In cases where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.
The situation highlights the ongoing challenges between accepting vital foreign assistance and protecting national sovereignty in an increasingly data-driven world.